R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Management affiliates, included contributions from existing shareholders, including 415 Capital and a strategic investor. R3 Vascular intends to allocate the funds to advance the ELITE FDA IDE pivotal trial of its c bioresorbable scaffold, MAGNITUDE®, specifically designed for treating peripheral arterial disease below the knee (BTK PAD).

Read full article here.